Covered recipient · General Payments record
NISHANT J PATEL
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,697.68
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $410.87 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $106.81 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $103.88 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $52.34 | 1 |
| PFIZER INC. | $46.41 | 3 |
| QOL Medical, LLC | $39.27 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.49 | 1 |
| Janssen Biotech, Inc. | $21.43 | 1 |
| Celgene Corporation | $13.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.21 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198054 | CMS |
| ABBVIE INC. | $15.16 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198056 | CMS |
| ABBVIE INC. | $19.12 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198058 | CMS |
| ABBVIE INC. | $16.15 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198060 | CMS |
| ABBVIE INC. | $30.17 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198062 | CMS |
| Boston Scientific Corporation | $27.27 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092600259 | CMS |
| Boston Scientific Corporation | $76.61 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092600261 | CMS |
| Celgene Corporation | $13.24 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101076992 | CMS |
| Janssen Biotech, Inc. | $21.43 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078712770 | CMS |
| PFIZER INC. | $15.52 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131864185 | CMS |
| PFIZER INC. | $15.52 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131989823 | CMS |
| PFIZER INC. | $15.37 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131190955 | CMS |
| QOL Medical, LLC | $39.27 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147716587 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.49 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153442999 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $52.34 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137650768 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.